Catherine H. Marshall, MD, MPH

Catherine H. Marshall, MD, MPH, is an Assistant Professor of Oncology in the Department of Oncology, Division of Genitourinary Oncology at the Johns Hopkins University School of Medicine in Baltimore, Maryland. Her clinical practice and research are focused on prostate cancer.

Articles by Catherine H. Marshall, MD, MPH

Catherine H. Marshall, MD, MPHCRPC | October 31, 2023
Drs. Marshall, Reimers, and Dorff discuss toxicities from single-agent and combination-based HR inhibitors.
View More
Catherine H. Marshall, MD, MPHCRPC | October 31, 2023
Drs. Marshall, Reimers, and Dorff discuss PARP inhibitor strategies for BRCA-mutated patients throughout the care continuum.
Catherine H. Marshall, MD, MPHCRPC | May 5, 2023
Drs. Marshall, Bryce, and Castro discuss incorporating mCRPC PARP inhibitor toxicity and outcomes data into practice.
Catherine H. Marshall, MD, MPHCRPC | May 5, 2023
Drs. Marshall, Bryce, and Castro discuss PARP inhibitor monotherapy vs in combination with AR-targeting agents for mCRPC.
Catherine H. Marshall, MD, MPHExpert Interviews | January 10, 2023
Dr. Catherine H. Marshall is interviewed on the use and future of chemotherapy for the treatment of advanced prostate cancer.
Catherine H. Marshall, MD, MPHJournal | November 30, 2022
Dr Catherine Handy Marshall gives prostate cancer patients care advice beyond appointments and medical interventions.
Catherine H. Marshall, MD, MPHJournal | November 11, 2022
Highlights from ASCO 2022, including the role of doublet therapy (ADT combined with a novel oral antiandrogen drug).